Cuong Do V
Cuong Do V's purchase track record
Cuong Do V has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/27/2026 | BIVI | $32K | pending | pending | — |
| 8/14/2026 | ADAG | $8K | pending | pending | — |
| 11/30/2023 | BIVI | $18K | -31.1% | -75.6% | +14.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Adagene's ADG138 IND approved by China's NMPA. China's National Medical Products Administration has cleared Adagene's Investigational New Drug application for ADG138, a HER2xCD3 bispecific T-cell engager. This regulatory step allows the company to proceed with clinical development of its proprietary SAFEbody technology in China. The stock is currently trading near its 52-week low, well below the average analyst target price.
Transaction History
| BIVI | ▲ Buy | Open Market | 15,210 | $32K | 8/27/2026 | View on chart |
| ADAG | ▲ Buy | Open Market | 2,000 | $8K | 8/14/2026 | View on chart |
| BIVI | ▲ Buy | Open Market | 5,000 | — | 8/7/2025 | View on chart |
| BIVI | ▲ Buy | Grant | 168,000 | $0 | 6/24/2024 | View on chart |
| BIVI | ▼ Sell | Tax Withholding | 42,000 | $20K | 6/24/2024 | View on chart |
| BIVI | ▲ Buy | Open Market | 10,000 | — | 3/4/2024 | View on chart |
| BIVI | ▼ Sell | Tax Withholding | 4,953 | $6K | 2/15/2024 | View on chart |
| BIVI | ▲ Buy | Open Market | 10,000 | $18K | 11/30/2023 | View on chart |
| BIVI | ▲ Buy | Grant | 149,500 | $0 | 6/29/2023 | View on chart |
| BIVI | ▲ Buy | Option Exercise | 41,506 | — | 6/21/2023 | View on chart |
| BIVI | ▼ Sell | Tax Withholding | 4,953 | $27K | 2/16/2023 | View on chart |
| BIVI | ▼ Sell | Tax Withholding | 4,953 | $30K | 2/16/2023 | View on chart |
| BIVI | ▲ Buy | Grant | 79,248 | $0 | 11/23/2022 | View on chart |
| BIVI | ▲ Buy | Grant | 21,710 | $0 | 12/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
BioVie Featured on Bloomberg Television Segment
BioVie was included in a new episode of The Street Show airing on Bloomberg Television. The segment also featured Glint, Sagtec Global, and SafeSpace Global. This media appearance provides additional visibility for the company to a financial audience.
BioVie Featured on Bloomberg Television Segment. BioVie was included in a new episode of The Street Show airing on Bloomberg Television. The segment also featured Glint, Sagtec Global, and SafeSpace Global. This media appearance provides additional visibility for the company to a financial audience.